Metastatic Breast Cancer Treatment
When breast cancer spreads to another part of the body, it is considered metastatic breast cancer. Metastases may develop in multiple organs and can show up as multiple tumors or lesions. Breast cancer metastasized to the lung is the most common diagnosis, developing in 80 percent of people who have a metastasis. Metastatic breast cancer in the liver happens in 50 percent of cases. Other organs are also involved in 50 percent of cases.
As soon as you are diagnosed with metastatic breast cancer, ask your physician these three questions.
The UF Metastatic Cancer Program’s integrated strategy offers comprehensive treatment through an aggressive new approach, working collaboratively with a patient’s existing medical oncologist and in tandem with standard chemotherapy.
The best chance at managing metastatic breast cancer is to act at the first sign of symptoms or immediately upon diagnosis. The UF Metastatic Cancer Program treats patients who have 10 or fewer new lesions.
Our method for treating cancer uses a targeted type of radiation called stereotactic body radiation therapy (SBRT) to pinpoint the metastatic lesions and destroy them on contact. Because SBRT has the ability to eliminate tumors with less damage to healthy tissue and a more comfortable recovery time than other methods for removal, it is particularly beneficial for patients who are not candidates for surgery.
If new tumors develop later and are identified early, SBRT is an effective method for elimination.
Additional therapies at the UF Metastatic Cancer Program include:
- Tumor immune therapy
- Tumor vaccine therapy
- Tumor anti-vascular therapy
- Interventional pulmonology
- Interventional radiology procedures
To begin the evaluation, complete the self-assessment questionnaire now.
To learn more or to make an appointment for a consultation, contact us today.